Substituted thioacetamides

Details for Australian Patent Application No. 2002349923 (hide)

Owner Cephalon, Inc.

Inventors Mallamo, John P; Miller, Matthew S; Dunn, Derek; Bacon, Edward R; Vaught, Jeffry L; Chatterjee, Sankar; Tripathy, Rabindranath

Agent Watermark

Pub. Number AU-B-2002349923

PCT Number PCT/US02/34188

PCT Pub. Number WO2003/037853

Priority 10/014,645 26.10.01 US

Filing date 25 October 2002

Wipo publication date 12 May 2003

Acceptance publication date 11 September 2008

International Classifications

C07C 317/44 (2006.01) Sulfones

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61K 31/341 (2006.01) - not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/4015 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4436 (2006.01)

A61K 31/45 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide

A61K 31/5377 (2006.01)

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/20 (2006.01) Drugs for disorders of the nervous system

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 10/014,645 26.10.01 US

10 July 2003 Application Open to Public Inspection

  Published as AU-B-2002349923

18 May 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 May 2006 Corrigenda

  Applications Lapsed, Refused or Withdrawn, Patents Ceased or Expired - 2002 Delete all reference to Application No. 2002349923

11 September 2008 Application Accepted

  Published as AU-B-2002349923

22 January 2009 Standard Patent Sealed

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002349924-32235, A HUMAN AMINOTRANSFERASE FAMILY MEMBER AND USES THEREFOR

2002349922-FLEXIBLE CONTAINER